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ApoptosisPhosphatidylinositol 3-kinase (PI3K)/Akt signaling is commonly activated upon virus infection and has been
implicated in the regulation of diverse cellular functions such as proliferation and apoptosis. The present
study demonstrated for the ﬁrst time that infectious bursal disease virus (IBDV), the causative agent of a
highly contagious disease in chickens, can induce Akt phosphorylation in cultured cells, by a mechanism that
is dependent on PI3K. Inhibition of PI3K activation greatly enhanced virus-induced cytopathic effect and
apoptotic cell death as evidenced by cleavage of poly-ADP ribose polymerase and activation of caspase-3.
Investigations into the mechanism of PI3K/Akt activation revealed that IBDV activates PI3K/Akt signaling
through binding of the non-structural protein VP5 to regulatory subunit p85α of PI3K resulting in the
suppression of premature apoptosis and improved virus growth after infection. The results presented here
provide a basis for understanding molecular mechanism of IBDV infection.l rights reserved.© 2011 Elsevier Inc. All rights reserved.1. Introduction
Infectious bursal disease virus (IBDV) is the etiological agent of
infectious bursal disease (IBD), which is a highly contagious disease in
3–15 week-old chickens. IBDV replicates in the cytoplasm of infected
cells and targets the precursors of antibody-producing B lymphocytes
in the bursa of Fabricius (BF). Infection by this virus leads to a severe
immunosuppression in young chickens, inducing increased suscepti-
bility to other pathogens as well as reduced efﬁcacy of vaccination
against other diseases (Lukert and Saif, 1997; Van Den Berg, 2000).
Two distinct serotypes (I and II) are recognized for IBDV (McFerran
et al., 1980). Serotype I virus strains differ markedly in virulence,
classic and very virulent IBDV strains cause hemorrhagic inﬂamma-
tion of the BF whereas variant strains cause rapid bursal atrophy
without evoking an inﬂammation response (Lukert and Saif, 1997;
Snyder et al., 1992). In contrast to serotype I, serotype II viruses are
naturally avirulent for chickens (Ismail et al., 1988). IBD is one of the
most important diseases affecting the poultry industry worldwide.
IBDV is a member of the genus Avibirnavirus within the family
Birnaviridae, and its genome consists of two segments of double-
stranded RNA, designated A (≈3.2 kb) and B (≈2.8 kb). Segment A
has two partially overlapping open reading frames (ORFs). The larger
ORF encodes a 110-kDa polyprotein precursor in the order NH2-pVP2-
VP4-VP3-COOH. The polyprotein appears to be cotranslationallyprocessed through the proteolytic activity of the viral protease, VP4,
to generate pVP2, VP4, and VP3 (Azad et al., 1985; Hudson et al., 1986;
Jagadish et al., 1988). pVP2 is further processed at its C terminus to
become VP2 through the cleavage of three alanine–alanine bonds and
an alanine–phenylalanine bond (Da Costa et al., 2002). VP2 and VP3
are structural proteins forming the virus capsid (Hudson et al., 1986).
The smaller ORF encodes a highly conserved, basic and cysteine-rich
class II membrane protein VP5 with a molecular weight of 17 kDa,
which is not required for viral replication (Mundt et al., 1997).
Segment B encodes VP1 which is known as a multifunctional protein
with polymerase and capping enzyme activities (Spies et al., 1987;
Spies and Müller, 1990).
IBDV infection has been shown to induce apoptosis both in vitro
and in vivo (Lam, 1997; Ojeda et al., 1997; Tanimura and Sharma,
1998; Vasconcelos and Lam, 1994). Besides VP2, an apoptotic inducer
(Fernández-Arias et al., 1997), VP5 was previously considered to be
involved in the induction of apoptosis and IBDV pathogenesis (Yao
et al., 1998; Yao and Vakharia, 2001). VP5 protein has also been shown
to accumulate within the host plasma membrane and induce the
release of viral particles (Lombardo et al., 2000; Wu et al., 2009).
Furthermore, an increased data demonstrated that VP5 has an
antiapoptotic function at the early stage of IBDV infection as
evidenced in the VP5-deﬁcient IBDV virus with more NF-κB activation
and higher caspase-3 and -9 activities than that in the parental IBDV
strain (Liu and Vakharia, 2006). However, whether there is an
alternative mechanism whereby VP5 inhibits apoptosis is not clear.
Phosphatidylinositol 3-kinase (PI3K) is a heterodimeric protein/
lipid kinase that consists of a regulatory subunit (usually p85α, p85β,
or p55γ), and a p110 catalytic subunit (α, β, γ, or δ) (Cantrell, 2001).
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trisphosphate from phosphatidylinositol 4,5-bisphosphate in the
membrane, which functions as a second messenger to recruit
pleckstrin homology domain-containing proteins, such as Akt (also
known as PKB) and phosphoinositide-dependent kinase 1. Akt/PKB is
a major PI3K effector and becomes further activated by phosphory-
lation at Thr308 and Ser473. Phosphorylated Akt plays an important
role in modulating diverse downstream signaling pathways associat-
ed with cell proliferation, migration, differentiation, and the preven-
tion of apoptosis (Datta et al., 1999; Yao and Cooper, 1995). The
modulation of host cell PI3K signaling is a target for many viruses and
induces a number of physiological changes within cells, from virus
entry through replication and enhanced cell survival and thereby
blockage of apoptosis in infected cells to oncogenic transformation as
well as virion assembly (Dawson et al., 2003; Esfandiarei et al., 2004;
Francois and Klotman, 2003; Fukuda and Longnecker, 2004; He et al.,
2002; Nair et al., 2003; Shih et al., 2000). To date, there is still no
report on the activation of PI3K/Akt induced by IBDV infection and the
possible roles of the PI3K/Akt signaling pathway in the IBDV-infected
cells.
Because IBDV appears to trigger apoptosis in the cultured cells at a
late stage of infection and the nonstructural protein VP5 mediates
antiapoptotic responses at the early stage of infection (Liu and
Vakharia, 2006), the possibility that the PI3K/Akt pathway partici-
pates in the preservation of host cell survival during viral infection has
prompted us to investigate the interaction between IBDV and this
pathway. In the present study, we show that Akt can be phosphor-
ylated after IBDV infection in the PI3K-dependent manner.When PI3K
was blocked by a speciﬁc inhibitor LY294002, IBDV infection resulted
in apoptosis at the early stage of infection; the inhibitor reduced IBDV
virus production but had no effect on viral RNA transcription and
protein synthesis. We also found that expression of VP5 alone was
sufﬁcient to activate the PI3K/Akt signaling but a VP5 knockout
mutant IBDV did not. By using co-immunoprecipitation assay, we
further found that VP5 binds to a PI3K regulatory subunit p85α, but
not p85β isoform, and activates PI3K, thus causing the activation of
the PI3K effector Akt. This results in more signiﬁcant apoptotic
responses during earlier stages of infection with the VP5 mutant.
These ﬁndings suggest that IBDV VP5 helps IBDV to activate the PI3K/
Akt signaling through interaction of VP5 with the regulator subunit
p85α of PI3K resulting in the suppression of premature apoptosis and
improved virus growth after infection.2. Results
2.1. PI3K-dependent Akt phosphorylation was induced by IBDV infection
Because IBDV infection induced apoptosis in the infected cells late
after infection (Liu and Vakharia, 2006), we speculated that a survival
signal might be triggered at the early stage of viral infection. Serum
starved DF-1 cells were infected with IBDV strain LM at a multiplicity
of infection (MOI) of 10 TCID50. Incubation with PBS served as mock-
infected controls. Cell lysates prepared at the predetermined times
were subjected to SDS–PAGE followed by Western blotting with the
antibody speciﬁc to phosphorylated-Akt (Ser473). As shown in
Fig. 1A, phosphorylated Akt was evident in virus-infected cells at
2 h and activation reached maximal levels at 10 h postinfection.
Phosphorylated Akt in 1 h cells was close to that observed in the
mock-infected cells (Fig. 1A). The increased phosphorylation of Akt
was not concurrent with expression of viral capsid protein VP2 in the
infected cells (Fig. 1A). The protein levels of total amounts of Akt
remain unchanged in the IBDV-infected cells at various time points
after infection when compared to that in the mock-infected cells. A
loading control, β-actin in each sample, was comparable. Similar
patterns of Akt activation were also observed in Vero cells followingIBDV strain LM infection (data not shown), eliminating a possible cell
line-speciﬁc phenomenon.
To further determine activated Akt quantitatively in the infected
cells, we used a FACE assay to investigate the levels of Akt
phosphorylation at the indicated time points after IBDV infection. As
shown in Fig. 1B, there was a time-dependent increase in the Akt
phosphorylation in the IBDV-infected cells until 10 h postinfection
which decreased thereafter. At 10 h after infection, the activation of
phosphorylated Akt was approximately 2.8-fold higher than that in
the mock-infected cells. In addition, the levels of total Akt remain
unchanged in the IBDV-infected cells at various time points after
infection when compared to that in the mock-infected cells.
Akt serves as a key downstream mediator of PI3K signaling (6, 7).
Thus, we continued to investigate whether the phosphorylation and
activation of Akt upon IBDV infection occurs through the PI3K
pathway. DF-1 cells were infected by LM strain at a MOI of 10
TCID50, followed by treatment with increasing doses (5, 10, 25, and
50 μM) of LY294002, a speciﬁc PI3K inhibitor. Cell lysates were
collected at 6 h postinfection and subjected to Western blotting
analysis to detect the phosphorylation of Akt on Ser473. As shown in
Fig. 1C, LY294002 treatment inhibited IBDV-induced Akt activation in
a dose-dependent manner. By the FACE assay, reductions in Akt
phosphorylation at 6 h postinfection inversely correlated with
increased amounts of LY294002 (Fig. 1D). The levels of total Akt
remained constant in all samples. Also, treatment of the IBDV-infected
cells by wortmannin, another speciﬁc PI3K inhibitor, gave results
similar to those observed for LY294002 (data not shown). These
results indicated that IBDV-induced Akt phosphorylation occurs
through a PI3K-dependent mechanism.
2.2. Blockage of PI3K activation enhanced cell death in IBDV-infected
cells but reduced virus release
Because PI3K/Akt activation is important for cell survival (Marte and
Downward, 1997), we determined whether activation of PI3K/Akt
signaling pathway by IBDV infection would affect cell viability.
Pretreatment of cells with LY294002 followed by IBDV infection caused
CPE as early as 24 h after infection in a dose-dependent manner while
the cells infected with IBDV but not pretreated with LY294002 showed
minimalmorphological changes (Fig. 2A). As observed for other viruses
(Lee et al., 2005), we also noticed that blocking of the PI3K activity has
shortened the time period of active viral production (2 days versus
3 days in the IBDV alone-infected cells) (data not shown), this is
probably due to the obvious loss of cells as shown in Fig. 2A.
To further determine whether activated PI3K/Akt play any role in
the replication of IBDV, we examine the effect of the PI3K/Akt on
progeny virus production in the IBDV-infected DF-1 cells by treatment
with the inhibitor LY294002. We infected DF-1 cells with IBDV in the
presence of the inhibitor LY294002 (25 or 50 μM) and determined the
virus titers in the cell culture supernatant at 8, 12, and 24 h
postinfection by using a TCID50 assay, as shown in Fig. 2B. For virus
production at 8 h postinfection, only a slight reduction of the virus
titer (0.25-log-unit reduction at 50 μM of LY294002 compared to the
titer of the no-treatment control) was observed. At 12 h postinfection,
the inhibitor resulted in reduction of virus yield (0.5-log-unit
reduction at 25 and 50 μM). At 24 h postinfection, treatment with
the inhibitor LY294002 at 25 and 50 μM reduced IBDV progenies by
1.0- and 1.5-log-unit, respectively. The result suggested that blockage
of PI3K activation reduced virus release.
To help delineate the mechanism of PI3K/Akt regulation of IBDV
infection, we examined the effect of PI3K/Akt inhibition on viral
protein expression. DF-1 cells infected with IBDV (MOI of 5) in the
presence of DMSO or LY294002 (12.5–50 μM) were harvested at the
predetermined time points and subjected to Western blotting using
antibody against VP2 protein. As shown in Fig. 2C, synthesis of
VP2 protein remains unchanged in LY294002-treated infected cells
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Fig. 1. Infectious bursal disease virus infection induces PI3K-dependent Akt phosphorylation. (A) Whole-cell lysates from serum-starved DF-1 cells after infection with IBDV strain
LM at a MOI of 10 TCID50. IBDV-infected cells were harvested at the indicated times postinfection, and were prepared and resolved by SDS–PAGE, transferred to nitrocellulose
membranes, and immunoblotted. The protein levels of Akt and its phosphorylated (Ser473) form, as well as IBDV VP2 protein, were analyzed. The amounts of β-actin were also
assessed to monitor the equal loadings of protein extracts. (B) Akt activation induced by IBDV infection was determined by using a FACE assay. DF-1 cells at the indicated time points
were ﬁxed with 4% formaldehyde and incubated with antibodies directed against Akt or its phosphorylated (Ser473) form followed by HRP-conjugated immunoglobulin G
antibodies. Akt and its phosphorylated form were each assayed in triplicate. Cell numbers were normalized by using crystal violet. These results are representative of three
independent experiments. Values are means±the SD from triplicate wells. *, Pb0.05 for a comparison of mock-infected and IBDV-infected cells. (C) Dose-dependent inhibition of
IBDV-induced Akt phosphorylation by treatment with PI3K inhibitor LY294002. DF-1 cells pretreated with increasing amounts (5, 10, 25, and 50 μM) of LY294002 for 30 min were
infected with the IBDV strain LM for 60 min followed by incubation for 6 h before the cell lysates were harvested for Western blotting as described in panel A. (D) Dose-dependent
inhibition of IBDV-induced Akt phosphorylation was further quantitatively determined by the FACE assay. LY294002-treated DF-1 cells at 6 h postinfection were ﬁxed and assayed
for Akt phosphorylation. These results are representative of three independent experiments. Values are means±the SD from triplicate wells. *, Pb0.05 for a comparison of IBDV-
infected and LY294002-treated IBDV-infected cells. p-, phosphorylated. SD, standard deviations.
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DMSO-treated infected cells at the tested time points. β-actin was
included as a loading control (Fig. 2C). We then examined the effect of
PI3K/Akt inhibition on IBDV viral mRNA synthesis, the real-time RT-
PCR analysis was performed with RNA extracted from DF-1 cells 12 h
after treatment with LY294002 at the increased concentrations. The
abundance of IBDV mRNA was detected in the LY294002-treated
IBDV-infected cells as seen in the IBDV-alone-infected cells (Fig. 2D).
No viral mRNA accumulation was detected in the mock-infected cells
(Fig. 2D). The results indicate that inhibition of PI3K/Akt activation did
not have an effect on viral protein synthesis and on the accumulation
of viral-speciﬁc mRNA in the IBDV-infected cells.
2.3. Inhibition of PI3K resulted in apoptotic cell death in the early stage
of IBDV infection
In general, activation of PI3K/Akt signaling suppresses apoptotic
responses via direct phosphorylation of caspase-9 and thereby
inhibition of activation of this apoptotic protease (Cardone et al.,
1998), as well as phosphorylation and inactivation of apoptosis-promoting activity of GSK-3β (Pap and Cooper, 1998). As demon-
strated above, blocking of PI3K activation enhanced cell death in the
IBDV-infected cells but reduced virus production, this might be due to
increased apoptotic responses. To elucidate the role of the PI3K/Akt
pathway in regulating apoptosis in the IBDV-infected cells, the
phosphorylation of caspase-9 and GSK-3β as direct downstream
targets of PI3K/Akt was analyzed. In the IBDV-infected cells,
immunoblots of protein lysates probed with phospho-speciﬁc anti-
bodies against caspase-9 and GSK-3β revealed increased levels of
caspase-9 and GSK-3β phosphorylation at 18 h postinfection which
decreased thereafter (Fig. 3A). This might be associated with
increased apoptotic responses induced by VP2 (Fernández-Arias
et al., 1997) at a late stage of infection. The increased levels of
caspase-9 and GSK-3β phosphorylation were signiﬁcantly blocked by
LY294002 treatment (Fig. 3A). We also measured the cleavage of
PARP, a major downstream substrate for activated caspase-9. As
shown in Fig. 3A, IBDV infection also caused PARP cleavage at 18 h
postinfection; however, when PI3K activation was blocked by
LY294002, IBDV induced PARP cleavage at the earlier time of 12 h
postinfection (Fig. 3A). A strong increase of PARP cleavage
214 L. Wei et al. / Virology 417 (2011) 211–220concomitant with a reduced phosphorylation of caspase-9 is observed
(Fig. 3A). This also coincides with a reduced phosphorylation of GSK-
3β. In addition, enhanced activities of caspase-3 were also detectableh42VDBIkcoM
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Fig. 3. An active PI3K/Akt pathway suppresses viral apoptosis induction via inactivation of Akt effectors GSK-3β and caspase-9. (A) DF-1 cells were treated with the PI3K inhibitor
LY294002 (20 μM) or equal volumes of the solvent (DMSO) after infection with the IBDV strain LM at aMOI of 10. At the indicated time points after infection, the cells were lysed and
phosphorylated Akt (Ser473) was detected by Western blotting. Induction of apoptosis-regulating markers, such as cleavage of PARP or phosphorylation of GSK-3β and caspase-9,
was detected with speciﬁc antibodies against PARP, phosphorylated GSK-3β and caspase-9. Equal protein loads were veriﬁed with β-actin blots. p-, phosphorylated. (B) Inhibition of
Akt activation enhances IBDV-induced caspase-3 activity. Whole-cell lysates harvested from IBDV-infected cells at the indicated time points after treatment with LY294002 (20 μM)
were assayed for DEVDase activity using the caspase-3 colorimetric DEVD-AFC. In addition, the cells infected with IBDV alone were treated with caspase-3 inhibitor DEVD-CHO.
Mock-infected cells were used as a negative control. The values shown are means from triplicate experiments.
215L. Wei et al. / Virology 417 (2011) 211–220Akt activation enhances the onset of premature virus-induced caspase
activation and apoptosis at the early stage of IBDV infection.
2.4. Expression of VP5 results in activation of the PI3K/Akt signaling
pathway
As demonstrated above, activation of the PI3K/Akt pathway was
observed upon IBDV infection. IBDV VP5 has been considered to
predominantly express at the early stage of infection (Mundt et al.,
1995), therefore, we investigated whether VP5 protein has a potential
role in activation of the PI3K/Akt pathway. For this, we generated a
recombinant rLM virus and its VP5 knockout mutant, rLMVP5Δ, using
reverse genetics. When DF-1 cells were infected with these two
viruses, no difference in viral protein synthesis (based on VP2
expression) was observed (data not shown). However, rLMVP5Δ
virus replicated slower and produced fewer progenies than its
counterpart, rLM virus, at 14 h postinfection (data not shown),
consistent with that of the previous report (Liu and Vakharia, 2006).
DF-1 cells were infected with wild-type LM, rLM, as well as rLMVP5Δ,
and cell lysates were prepared at 8 h postinfection. The phosphory-
lation of Akt (Ser473) was analyzed by Western blotting. As shown in
Fig. 4A, the wild-type LM as well as recombinant rLM virus infection
resulted in induction of phospho-Akt compared to the VP5 mutant
rLMVP5Δ, which resulted in weak phosphorylation of Akt. As
expected, the PI3K inhibitor LY294002 resulted in blockage of Akt
phosphorylation in the wild-type LM as well as recombinant rLM-Fig. 2. Effects of PI3K activation in IBDV-infected DF-1 cells. (A) Morphology of IBDV-infe
containing 2% FBS overnight. The cells were then pretreated with various concentrations of
After 1 h of viral adsorption, the cells were washed and replenished with fresh media with 2%
was photographed. (B) Inhibition of Akt phosphorylation blocks IBDV production. Supern
concentrations of LY294002 were inoculated on monolayers of DF-1 cells. Virus productio
experiments. *, Pb0.05 for a comparison of IBDV-infected and LY294002-treated IBDV-infe
prepared from infected cells 12 and 24 h after treatment with the increased concentration
expression in the IBDV-infected cells. Equal protein loads were veriﬁed with β-actin blots.
isolated from the IBDV-infected cells 12 h after treatment with LY294002 were subjected to
expressed as percentages of the normalized value for IBDV-infected cells after treatment w
independent experiments.infected cells (Fig. 4A). Similar results were obtained in Vero cells
(data not shown). To rule out effects of other IBDV proteins or dsRNA-
mediated effects, pCMV-VP5 plasmidwas transfected in Vero cells and
activated Akt was quantitatively determined. As shown in Fig. 4B, the
activation of phosphorylated Akt at 24 h post-transfection showed
approximately 2.9- and 1.9-fold higher than that in the mock-
transfected and empty vector-transfected cells, respectively. In
addition, the levels of total Akt remain unchanged in the pCMV-VP5
plasmid after transfection when compared to that in the mock-
transfected as well as empty vector-transfected cells. Therefore, these
results indicated that IBDV VP5 alone is sufﬁcient to activate the PI3K/
Akt signaling pathway.
2.5. VP5 protein binds to p85α regulatory subunit of PI3K
To conﬁrm whether activation of PI3K/Akt is due to modulation of
cellular signaling mechanism or to protein–protein interaction of VP5
with PI3K, VP5 and p85α or p85β full-length genes were inserted into
an expression vector that allows the production of HA or myc fusion
protein. Vero cells were transfected with pCMV-VP5 plasmid expres-
sing HA-tagged VP5, analysis of proteins immunoprecipitated with
the anti-HA antibody revealed that VP5 efﬁciently precipitated
endogenous p85α rather than p85β subunit (data not shown). Also,
a reciprocal speciﬁc coimmunoprecipitation of HA-VP5 and myc-
p85α was observed with anti-myc antibody in Vero cells co-
transfected with HA-VP5 and myc-p85α plasmids (Fig. 5A). Ascted DF-1 cells when PI3K activation is blocked. DF-1 cells were cultured in medium
LY294002 or just solvent control for 30 min and then infected with the IBDV strain LM.
FBS and various concentrations of LY294002. At 24 h postinfecton, the cell morphology
atants of the IBDV-infected DF-1 cells at 8, 12, and 24 h after treatment with various
n was determined by TCID50 assay. Values represent the means of three independent
cted cells. (C) Effect of PI3K inhibitor on IBDV protein expression. Whole-cell extracts
s of the inhibitor LY294002 were assayed by Western blotting for the presence of VP2
(D) Effect of PI3K inhibitor on IBDV viral mRNA synthesis in infected cells. Total RNAs
a real-time RT-PCR analysis of VP2 RNA. Data are normalized to β-actin mRNA and are
ith LY294002 over IBDV alone-infected cells; they are means±SD of values from three
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Fig. 4. IBDV-induced PI3K/Akt activation is VP5 dependent. (A) Western blot analysis
showing phosphorylation of Akt (Ser473) at 8 h postinfection with the wild-type and
mutant virus (MOI of 10) in the DF-1 cells. β-actin expression was monitored as a
loading control. p-, phosphorylated. (B) Akt phosphorylation level was determined by
using FACE assay after overexpression of VP5 with respect to the vector-transfected
control. Vero cells at 24 h transfection were ﬁxed with 4% formaldehyde and incubated
with antibodies directed against Akt or its phosphorylated (Ser473) form followed by
HRP-conjugated immunoglobulin G antibodies. Akt and its phosphorylated form were
each assayed in triplicate. Cell numbers were normalized by using crystal violet. The
result is representative of three independent experiments. Values are means±the SD
from triplicate wells. *, Pb0.05 for a comparison of mock-transfected and HA-VP5
plasmid-transfected cells.
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plasmid alone-transfected cell lysate to anti-HA agarose (Fig. 5A). In
contrast, HA-VP5 does not bind to myc-p85β in the HA-VP5 and myc-
p85β plasmids-co-transfected cells (Fig. 5B). The result showed that
VP5 and p85α physically and speciﬁcally interact in vivo.2.6. VP5 protein suppresses apoptotic responses via activating PI3K/Akt
signaling
VP5 has been shown to inhibit virus-induced apoptosis in the early
stage of IBDV infection (Liu and Vakharia, 2006). To investigate
whether VP5 protein suppresses apoptotic responses through
activation of the PI3K/Akt pathway, the wild-type IBDV strain LM,
recombinant rLM as well as mutant virus rLMVP5Δ at a MOI of 10
TCID50 were inoculated into DF-1 cells and PI3K/Akt activation-
mediate apoptotic events were determined. At 12 h postinfection, cell
lysates were prepared and subjected to Western blotting with
antibodies against p-caspase-9 (Ser196) as well as p-GSK-3β
(Fig. 6A). Elevated p-caspase-9 as well as p-GSK-3β was detected in
the wild-type- and rLM-infected cells, as well as in the mock-infected
cells. However, no obvious phosphorylation of caspase-9 as well as p-
GSK-3β occurred in the cells infected by the rLMVP5Δ virus-infected
cells as well as the wild-type- and rLM-infected cells after treatment
with LY294002 (20 μM) (Fig. 6A). We then examined whether
phosphorylation of caspase-9 would lead to inhibition of PARP
cleavage in the mutant virus-infected cells. As shown in Fig 6A, aFig. 5. Interaction of IBDV VP5 protein with p85α regulator subunit of PI3K. Coimmunoprec
using HA-speciﬁc antibody. Left panels in A and B show protein expression in whole-cell ext
vectors. WB, Western blotting; IP, immunoprecipitation; α, anti.cleaved PARP band was clearly visible in the rLMVP5Δ-infected cells
as well as the wild-type- and rLM-infected cells after treatment with
LY294002. A weak cleaved PARP band was detected in the wild-type-,
rLM-, and mock-infected cells, indicating that PARP cleavage was
inhibited to some extent. Equal loading of the cellular protein was
monitored by determining β-actin level.
This was further conﬁrmed by quantitating the protease activity of
caspase-3 by using the ﬂuorometric assay. There was a signiﬁcant
increase in caspase-3 activity (2.26- to 2.34-fold) at 12 h postinfection
in themutant virus-infected cells compared to that in thewild-type as
well as rLM-infected cells. In addition, a peptide inhibitor of caspase-3
activity, Ac-DEVD-CHO, was used as an internal control to conﬁrm
assay validity. The caspase-3 activity was also measured in the cells
infected with the wild-type as well as rLM virus after inhibition of
PI3K/Akt activation. As expected, enhanced caspase-3 activities were
observed in the wild-type as well as rLM virus-infected cells in the
presence of LY294002 (Fig. 6B).3. Discussion
PI3Ks, a family of heterodimeric enzymes are activated by binding to
Src homology-2 or -3 (SH2or SH3) domains of the proteins to thep85or
p110 subunits (Datta et al., 1999). Activated PI3K can further activate
downstream protein or lipid kinases, including major target Akt.
Activated Akt plays a central role in modulating diverse downstream
signaling pathways associated with differentiation, proliferation, and
thepreventionof apoptosis (Datta et al., 1999;YaoandCooper, 1995). In
the case of viruses causing acute infections, such as dengue virus (Lee
et al., 2005), inﬂuenza virus (Ehrhardt et al., 2006 & 2007), coxsack-
ievirus B3 (Esfandiarei et al., 2004), poliovirus (Autret et al., 2008),
vaccinia virus, cowpox virus (Soares et al., 2009), and rotavirus (Bagchi
et al., 2010), PI3K/Akt signaling has been reported to assist viral
replication by inhibiting apoptosis. In this study, we report that
infectious bursal disease virus infection activates the PI3K/Akt pathway,
protecting the cells from caspase-mediated apoptotic cell death during
the early stage of viral infection. The PI3K/Akt signaling is involved in
IBDV replication, as the PI3K inhibitor LY294002 did reduce infectious
virus production. Furthermore, the PI3K/Akt pathway activation is
attributed to the viral VP5 protein which can speciﬁcally interact with
PI3K regulatory subunit p85α. The activation of PI3K confers an
antiapoptotic signal in the VP5-expressing cells, indicating that VP5
inhibits premature apoptosis induction to ensure efﬁcient replication
via activation of the PI3K/Akt signaling.
Activation of the PI3K/Akt pathway has been demonstrated to
occur during the early phase of infection by a variety of viruses and
the signaling participates in virus replication via prolonging survival
of infected cells and creating a favorable environment for virus
growth and virion assembly (Corray, 2004; Ehrhardt and Ludwig,
2009; Ji and Liu, 2008). We examined whether the PI3K/Akt pathway
plays a role in virus replication by blocking PI3K activity with theipitation of HA-VP5 protein with myc-p85α (A) rather than p85β (B) in the Vero cells
racts of input samples. Proteins were expressed by transfection with the corresponding
Fig. 6. IBDV VP5 inhibits virus-induced premature apoptosis. (A) DF-1 cells were infected with the wild-type, recombinant, or mutant LM virus. Cell lysates were prepared at 12 h
postinfection, and Western blot analysis was performed to detect the expression of cleaved PARP, as well as of phosphorylated GSK-3β and caspase-9. β-actin was used as an
endogenous control for equal protein loading. (B) At 12 h postinfection, caspase-3 activity was measured in DF-1 cells infected with the wild-type, recombinant (Re), or mutant
(Mut) LM strains, using the ﬂuorogenic substrate DEVD-AFC, revealed higher caspase-3 activity in the mutant virus-infected cells compared to the wild-type as well as recombinant
virus-infected cells. In the presence of PI3K inhibitor LY294002 (20 μM), increased caspase-3 activity was observed. Caspase-3 inhibitor DEVD-fmk was used as an internal control.
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inhibited virus production in the infected cells (Fig. 2B). This indicates
that activation of the PI3K/Akt pathway plays a role in supporting
IBDV propagation. Similar observations were reported in other
viruses, such as inﬂuenza A virus (Ehrhardt et al., 2006; Shin et al.,
2007), parainﬂuenza virus 5 (Sun et al., 2008), vaccinia and cowpox
virus (Soares et al., 2009), and so on, whereinwe found that inhibition
of PI3K/Akt results in reductions of virus release. To further deﬁne at
which step virus replication was affected, we found that inhibition of
PI3K/Akt activation did not have an effect on viral protein synthesis
and the accumulation of viral-speciﬁcmRNA in the IBDV-infected cells
(Fig. 3C and D). This result appears to be in disagreement with the
ﬁnding that inhibition of PI3K/Akt activation reduces IBDV release
from the infected cells. However, this can be explained since
inhibition of IBDV-mediated PI3K/Akt activation may be resistant to
the translational blockage triggered by the PI3K inhibitor as described
in ﬂavivirus (Lee et al. 2005) but blocks virus release from the infected
cells at the early stage of infection, which is similar to that in the
mutant IBDV virus lacking expression of VP5 protein (Liu and
Vakharia, 2006). In addition, the function of VP5 protein that
promotes virion release from the infected cells (Lombardo et al.,
2000; Wu et al., 2009) may be blocked after inhibition of PI3K/Akt
activation, whereby leading to reductions of virus production. Thus,
this implicates that the nonstructural protein VP5 is involved in the
IBDV-mediated PI3K/Akt activation.
By using a genetic approach, we constructed amutant virus lacking
the expression of VP5 protein and investigated the contribution of
VP5 to the PI3K/Akt signaling activation. The mutant virus infection
did not lead to Akt phosphorylation at Ser473, suggesting that the VP5
protein is required for PI3K/Akt pathway activation. Inﬂuenza A virus
infection has been shown to activate the PI3K/Akt pathway by direct
interaction of the SH3 binding motif of NS1 protein with the p85β
subunit of PI3K (Ehrhardt et al., 2007; Hale et al., 2008; Hale et al.,
2006; Hale et al., 2010; Shi et al., 2007). Rotavirus NSP1 interacts with
the p85α subunit of PI3K and modulates sustained PI3K/Akt
activation in the virus-infected cells (Bagchi et al., 2010). Sequence
analysis revealed that IBDV VP5 protein contains three polyproline
motifs with the consensus sequence PXXP positioned at aa 76–79,
102–105, and 145–148. Such SH3 binding motifs are involved in the
PI3K signaling and form extended helices that bind to SH3 domainsfound within a diverse group of signaling proteins, including the p85
subunit (Pawson, 1995). Coimmunoprecipitation assay demonstrated
that VP5 binds speciﬁcally and efﬁciently to the p85α subunit of PI3K
but not to the related p85β isoform (Fig. 5A and B), suggesting that
activation of PI3K could be due to an interaction of VP5 with PI3K.
Therefore, the mechanism of PI3K/Akt activation induced by IBDV
involves a direct interaction between VP5 protein and p85α of PI3K.
However, whether the interaction of one or several SH3 binding
motifs of VP5 with the p85α subunit of PI3K may contribute to the
PI3K/Akt signaling pathway activation in the cultured cells is to be
further determined.
Activation of PI3K/Akt is a strategy adopted by many viruses to
prolong cell survival and block early premature apoptosis. Activated
Akt phosphorylates a large number of substrates, such as proapoptotic
protease caspase-9 and GSK-3β. This can lead to phosphorylation and
inactivation of the caspase-9 and GSK-3β and silences the apoptosis-
promoting activities. Our results showed that the wild-type virus
infection, which activates the PI3K/Akt pathway, resulting in
phosphorylation of caspase-9 and GSK-3β, does not induce obvious
caspase-3 apoptotic activity at the early stage of virus infection
(Fig. 3A and B). The role of the PI3K/Akt pathway in delaying
apoptosis in the wild-type virus was conﬁrmed; as high levels of PARP
cleavage or caspase-3 activity were earlier observed after the wild-
type virus infection in the presence of PI3K inhibitor (Fig. 3A and B).
Furthermore, signiﬁcantly high levels of PARP cleavage or caspase-3
protease activity were observed earlier in the cells infected with the
mutant virus rLMVP5Δ (Fig. 6A and B), which lacks the ability to
activate PI3K/Akt pathway (Fig. 4A). These results are consistent with
the reports showing a role for NS proteins in suppressing premature
apoptosis during infection with respiratory syncytial virus (Thomas
et al., 2002), poliovirus (Autret et al., 2008), inﬂuenza A virus
(Ehrhardt et al., 2007; Shi et al., 2007), and rotavirus (Bagchi et al.,
2010). Delayed apoptosis could encourage virus growth via retaining
cellular structural integrity beneﬁcial to optimal viral replication as
well as complete formation of packaged infectious virions (Bagchi
et al., 2010; Bitko et al., 2007; Kallewaard et al., 2005). Therefore, we
expand the data by identiﬁcation of the functional consequences of VP5-
mediated PI3K activity, namely, suppressing the onset of premature
virus-induced caspaseactivationandapoptosis in the early stage of IBDV
infection.
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signaling triggered by the PI3K/Akt pathway upon infectious bursal
disease virus infection does play an important role in viral replication
and regulation of apoptosis. IBDV-mediated PI3K/Akt activation is due
to speciﬁc interaction of VP5 protein with PI3K regulatory subunit
p85α, but not p85β isoform. The role of VP5 protein in mediating
antiapoptotic responses via activation of the PI3K/Akt pathway will
contribute to important information about the molecular mechanism
of IBDV pathogenesis.
3. Materials and methods
3.1. Virus and cells
A DF-1 chicken embryo ﬁbroblast (CEF) cell line (Himly et al.,
1998) wasmaintained in Dulbecco's Modiﬁed Eagle medium (DMEM)
(GIBCO) supplemented with 10% heat-inactivated fetal bovine serum
(FBS), 100 U/ml of penicillin G, and 100 μl/ml streptomycin at 37 °C in
a humidiﬁed 5% CO2 incubator. Vero cells were maintained in DMEM
medium supplemented with 5% FBS at 37 °C in a humidiﬁed 5% CO2
incubator and used for transfection and propagation. The IBDV
strain LM (Liu et al., 2002), a CEF cell-adapted virus, was used in the
study.
3.2. Reagents and antibodies
The PI3K inhibitor LY294002 and wortmannin were purchased
from Calbiochem (La Jolla, CA). DF-1 cells were treated with either
dimethyl sulfoxide (DMSO)which is the solvent for these inhibitors or
various concentrations (5–50 μM) of these two inhibitors for 1 h prior
to infection. After 1 h of virus adsorption, the virus inoculum was
removed and fresh basal medium containing fresh inhibitor was
added to the culture. The cytotoxicity of the inhibitors on DF-1 cells
was determined by trypan blue exclusion dye staining. It was noted
that throughout all doses of the inhibitors used in the present study,
cell viability assay showed no detectable cell death in the DF-1 cells.
Rabbit, goat, or mouse antibodies against Akt1/2/3, poly-ADP-ribose
polymerase (PARP), glycogen synthase kinase-3β (GSK-3β), phosphor-
ylated (p)-Akt (Ser473), -caspase-9 (Ser196), and β-actin were
purchased from Santa Cruz Biotechnology. Rabbit antibody against HA
and mouse monoclonal antibody against myc were purchased from
Clontech. Horseradish peroxidase (HRP)-linked secondary antibodies
were purchased from Sigma. Fluorescein isothiocyanate (FITC)- and
rhodamine-conjugated secondary antibodies were purchased from
DAKO.
3.3. FACE
Fast activated cell-based enzyme-linked immunosorbent assay
(FACE) kit to monitor the levels of Akt activation was obtained from
Active Motif. Procedure was performed strictly according to the
manufacturer's instructions. Brieﬂy, DF-1 or Vero cells seeded in 96-
well plates for 1 day were infected with IBDV strain LM or transfected
with plasmid pCMV-VP5 and ﬁxed with 4% formaldehyde in
phosphate-buffered saline (PBS) at the indicated time points after
infection or transfection. After washing and blocking steps, the cells
were reacted overnight with an anti-Akt or anti-phospho-Akt antibody.
Following incubation with an HRP-conjugated secondary antibody,
colorimetric analysis was performed. The A450was determined using a
plate spectrophotometer.
3.4. Real-time RT-PCR
Total cell RNAs were prepared from virus-infected DF-1 cells 12 h
after being treated with 20 μM of LY294002 by using RNeasy Mini kit
(Qiagen) for reverse transcription (RT)-PCR. The VP2-F5 (5′-CTGAC-TACCGGCATCGACA-3′) and VP2-R3 (5′-CCACTTGCCGACCATGA-3′)
primer pair was used to amplify a 133-nucleotide region of VP2, and
were normalized with β-actin primers (sense, 5′-GAGAAATTGTGCGT-
GACATCA-3′; antisense, 5′-CCTGAACCTCTCATTGCCA-3′) in separate
reactions. Real-time RT-PCR protocol followed the instructions of an
iScript one-step RT-PCR kit with SYBR Green (Bio-Rad). The RT-PCR
parameters consisted of a cDNA synthesis at 50 °C for 10 min and
reverse transcriptase inactivation at 95 °C for 5 min, followed by PCR
cycling and detection of 95 °C for 10 s and 55 °C for 30 s (40 cycles).
Each sample was run in triplicate. The relative amount of target viral
mRNA was normalized to that of β-actin mRNA in the same sample.
3.5. Virus titration
The amount of IBDV produced was measured on monolayers of
DF-1 cells. Cell supernatant was serially diluted and inoculated on
monolayers of DF-1 cells. Following 1 h of incubation, fresh DMEM
medium was added and incubated. Three days post-infection,
cytopathic effect (CPE) was observed under a microscope and virus
titer was determined as 50% tissue culture infective dose (TCID50) per
0.1 milliliter.
3.6. Whole cell lysates
Whole cell lysate extracts from DF-1 or Vero cells at the indicated
time points after infection or transfection were prepared with the
nuclear extract kit (Active Motif) according to the manufacturer's
protocol.
3.7. Generation of VP5 mutant virus
All manipulations of DNAs were performed according to standard
protocols. Recombinant plasmids pCI-LMA and pCI-LMB, containing
the complete genomic A and B segments, respectively, of IBDV strain
LM were used as templates. To construct a mutant cDNA clone of
segment A lacking the initiation codon of the VP5 gene, a set of
primers (LM△VP5-F: 5′-CGCTATCATTGATCGTCAGTAGAGATC-3′, and
LM△VP5-R: 5′-GCGATAGTAACTAGCAGTCATCTCTAG-3′)were synthe-
sized and used for PCR ampliﬁcation of the mutant plasmid pCI-LMA-
VP5△ using a QuickChange site-directed mutagenesis kit (Stratagene).
The mutant clone of segment A in which a mutation of the VP5 gene
initiation codon fromATG to ATCwas obtained after being sequenced to
conﬁrm that no errors were introduced as a result of PCR ampliﬁcation.
DF-1 cells were co-transfected with plasmids pCI-LMA or pCI-
LMA-VP5△ and pCI-LMB for generating recombinant IBDV (rLM) or
mutant IBDV (rLMVP5△), respectively. For the infection test, the
transfected cells were subjected to three successive freeze–thaw
cycles. The total lysates were collected and used to infect DF-1 cells.
They were then analyzed by indirect ﬂuorescence assay (IFA) after
infection. The mutant virus was passaged ﬁve times in DF-1 cells to
increase virus titers.
3.8. Coimmunoprecipitation analysis
To prepare recombinant eukaryotic expression plasmids, the
coding sequences of PI3K regulatory subunits p85α and p85β
(GenBank accession numbers XM_424759 and XM_001233340,
respectively) as well as IBDV strain LM VP5 gene were ampliﬁed
by RT-PCR reaction using three pairs of primers from primary
CEF cells and IBDV-infected cells. The following primers: myc-
p85α(F): 5′-CGGAATTCGGATGAGTGCTGAAGGAT-3′ and myc-
p85α(R): 5′-TTGTCGACTCATCGCCTCTGCTGTG-3′, myc-p85β(F):
5′-TTGAATTCTTATGGGCAGCACTGACGG-3′ and myc-p85β(R): 5′-
TTTCTAGATCATCTGGCTGGTGGCTGGGAAAGG-3′, HA-VP5(F): 5′-
GCGAATTCCGATGGTYAGTAGAGATCAGAC-3′ and HA-VP5(R): 5′-
GCAGATCTTCACTCAGGCTTCCTTG-3′, were used to amplify the
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fragments p85α, p85β, and VP5 were directionally cloned between
corresponding sites of eukaryotic expression vectors pCMV-myc and
pCMV-HA (Clontech), downstream of the human cytomegalovirus
(HCMV) promoter, to obtain myc-p85α and -p85β, as well as HA-
VP5, respectively.
In vitro expression of the myc-p85α, myc-p85β and HA-VP5 con-
structs was tested in transient expression experiments using Vero
cells. The cells grown in 25×25 mm ﬂasks were transfected or co-
transfected HA-VP5 or/and myc-p85α or myc-p85β (2 μg of plasmid
per ﬂask), using Lipofectamine 2000 (Invitrogen), as described in the
manufacturer's protocol. After 24 h posttransfection, the expression of
HA-VP5, myc-p85α or myc-p85β was demonstrated by immunoblot-
ting analysis using rabbit anti-HA polyclonal antibody or mouse anti-
myc monoclonal antibody.
Vero cell lysate extracts at 24 h after transfection with plasmid
pCMV-HA-VP5 as well as co-transfection with plasmids pCMV-HA-
VP5 and pCMV-myc-p85α or pCMV-myc-p85β were prepared for
immunocipitation analysis with profoundmammalian HA tag IP/Co-IP
kit (Pierce) according to the manufacturer's protocol. Lysate extracts
were incubated overnight at 4 °C with high afﬁnity anti-HA antibody-
coupled agarose. Bound proteins were eluted from agarose by boiling
them with Laemmli sample buffer and separated by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) before West-
ern blotting.
3.9. Western blotting
The whole cell lysate extracts prepared were diluted in 2× sample
buffer and boiled for 5 min. Twenty micrograms of each extract was
resolved on 10%–12% SDS–PAGE and blotted onto nitrocellulose (NC)
membranes (Stratagene) with a semidry transfer cell (Bio-Rad). The
membranes were blocked for 2 h at room temperature in blocking
buffer TBST (20 mM Tris–HCl [pH 7.4], 150 mM NaCl, 0.1% Tween-20)
containing 5% skim milk powder to prevent nonspeciﬁc binding, and
then incubated with speciﬁc primary antibodies raised against VP2,
Akt1/2/3, GSK-3β, PARP, myc, HA, phosphorylated (p)-Akt (Ser473),
-caspase-9 (Ser196), as well as β-actin at room temperature for 2 h.
The membranes were washed three times with TBST buffer, and
incubated for 2 h at room temperature with HRP-conjugated secondary
antibodies diluted in blocking buffer. Immunoreactive bands were
visualized by enhanced chemiluminescence system (Kodak Image
Station 4000R).
3.10. Fluorimetric assay of caspase activity
Spectroﬂuorometric assay of proteolytic activitywas carried out using
synthetic ﬂuorogenic substrate 7-amino-4-triﬂuoromethyl coumarin
(AFC) to measure caspase-3 activity. BD apoAlert caspase ﬂuorescent
assay kit (Clontech) was used to determine caspase-3 activity. In brief,
80% conﬂuent monolayers of DF-1 cells grown on T-25 ﬂasks were
infected with IBDV strain LM with or without the inhibitor LY294002
treatment after infection. At the indicated time points post-infection, the
cellswere harvested at 400g for 5 min. The cells (2–3×106)were lysed in
50 μl of lysis buffer on ice for 10 min and centrifuged at 16,000g for
10 min, and the supernatant was collected. A 50-μl supernatant was
added to an equal volume of 2× reaction–dithiothreitol buffer supple-
mented with caspase-3 substrate DEVD-AFC, and incubated at 37 °C for
2 h. The optical densities at 400 nm for caspase-3 were determined. The
nanomoles of AFC (released) expressed per hour was calculated from the
standard curve.
3.11. Statistical analysis
Results are presented as averages±the standard deviations or
standard errors of the means, as indicated. Statistical comparisons aremade by using Student's t test, and differences between groups were
considered signiﬁcant if the P value wasb0.05.Acknowledgment
This study was supported by the earmarked fund for Modern Agro-
Industry TechnologyResearchSystemofChina (Grantnycytx-42-G3-05).References
Autret, A., Martin-Latil, S., Brisac, C., Mousson, L., Colbère-Garapin, F., Blondel, B., 2008.
Early phosphatidylinositol-3-kinase/Akt pathway activation limits poliovirus-
induced JNK-mediated cell death. J. Virol. 82, 3796–3802.
Azad, A.A., Barrett, S.A., Fahey, K.J., 1985. The characterization and molecular cloning of
the double-stranded RNA genome of an Australian strain of infectious bursal
disease virus. Virology 143, 35–44.
Bagchi, P., Dutta, D., Chattopadhyay, S.,Mukherjee, A., Halder, U.C., Sarkar, S., Kobayashi, N.,
Komoto, S., Taniguchi, K., Chawla-Sarkar, M., 2010. Rotavirus nonstructural protein 1
suppresses virus-induced cellular apoptosis to facilitate virus growthby activating the
cell survival pathways during early stages of infection. J. Virol. 84, 6834–6845.
Bitko, V., Shulyayeva, O., Mazumder, B., Musiyenko, A., Ramaswamy, M., Look, D.C.,
Barik, S., 2007. Nonstructural proteins of respiratory syncytial virus suppress
premature apoptosis by an NF-κB-dependent, interferon-independent mechanism
and facilitate virus growth. J. Virol. 81, 1786–1795.
Cantrell, D.A., 2001. Phosphoinositide 3-kinase signalling pathways. J. Cell Sci. 114,
1439–1445.
Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F., Stanbridge, E., Frisch, S.,
Reed, J.C., 1998. Regulation of cell death protease caspase-9 by phosphorylation.
Science 282, 1318–1321.
Corray, S., 2004. The pivotal role of phosphatidylinositol 3-kinase-Akt signal
transduction in virus survival. J. Gen. Virol. 85, 1065–1076.
Da Costa, B., Chevalier, C., Henry, C., Huet, J.-C., Petit, S., Lepault, J., Boot, H., Delmas, B.,
2002. The capsid of infectious bursal disease virus contains several small peptides
arising from the maturation process of pVP2. J. Virol. 76, 2393–2402.
Datta, S.R., Brunet, A., Greenberg, M.E., 1999. Cellular survival: a play in three Akts.
Genes Dev. 13, 2905–2927.
Dawson, C.W., Tramountanis, G., Eliopoulos, A.G., Young, L.S., 2003. Epstein–Barr virus
latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt
pathway to promote cell survival and induce actin ﬁlament remodeling. J. Biol.
Chem. 278, 3694–3704.
Ehrhardt, C., Ludwig, S., 2009. A new player in a deadly game: inﬂuenza viruses and the
PI3K/Akt signaling pathway. Cell. Microbiol. 11, 863–871.
Ehrhardt, C., Marjuki, H., Wolff, T., Nürnberg, B., Planz, O., Pleschka, S., Ludwig, S., 2006.
Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during inﬂuenza virus
infection and host cell defense. Cell. Microbiol. 8, 1336–1348.
Ehrhardt, C., Wolff, T., Pleschka, S., Planz, O., Beermann, W., Bode, J.G., Schmolke, M.,
Ludwig, S., 2007. Inﬂuenza A virus NS1 protein activates the PI3K/Akt pathway to
mediate antiapoptotic signaling responses. J. Virol. 81, 3058–3067.
Esfandiarei, M., Luo, H., Yanagawa, B., Suarez, A., Dabiri, D., Zhang, J., McManus, B.M.,
2004. Protein kinase B/Akt regulates coxsackievirus B3 replication through a
mechanism which is not caspase dependent. J. Virol. 78, 4289–4298.
Fernández-Arias, A., Martínez, S., Rodríguez, J.F., 1997. The major antigenic protein of
infectious bursal disease virus, VP2, is an apoptotic inducer. J. Virol. 71, 8014–8018.
Francois, F., Klotman, M.E., 2003. Phosphatidylinositol 3-kinase regulates human
immunodeﬁciency virus type 1 replication following viral entry in primary CD4+ T
lymphocytes and macrophages. J. Virol. 77, 2539–2549.
Fukuda, M., Longnecker, R., 2004. Latent membrane protein 2A inhibits transforming
growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/
Akt pathway. J. Virol. 78, 1697–1705.
Hale, B.G., Batty, I.H., Downes, C.P., Randall, R.E., 2008. Binding of inﬂuenza A virus NS1
protein to the inter-SH2 domain of p85β suggests a novel mechanism for
phosphatidylinositol 3-kinase activation. J. Biol. Chem. 283, 1372–1380.
Hale, B.G., Jackson, D., Chen, Y.-H., Lamb, R.A., Randall, R.E., 2006. Inﬂuenza A virus NS1
protein binds p85β and activates phosphatidylinositol 3-kinase signaling. Proc.
Natl. Acad. Sci. U. S. A. 103, 14194–14199.
Hale, B.G., Kerry, P.S., Jackson,D., Precious, B.L., Gray,A., Killip,M.J., Randall, R.E., Russell, R.J.,
2010. Structural insights into phosphoinositide 3-kinase activation by the inﬂuenza A
virus NS1 protein. Proc. Natl. Acad. Sci. U. S. A. 107, 1954–1959.
He, Y., Nakao, H., Tan, S.L., Polyak, S.J., Neddermann, P., Vijaysri, S., Jacobs, B.L., Katze, M.G.,
2002. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A
protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J. Virol. 76,
9207–9217.
Himly, M., Foster, D.N., Bottoli, I., Iacovoni, J.S., Vogt, P.K., 1998. The DF-1 chicken
ﬁbroblast cell line: transformation induced by diverse oncogenes and cell death
resulting from infection by avian leukosis viruses. Virology 248, 295–304.
Hudson, P.J., McKern, N.M., Power, B.E., Azad, A.A., 1986. Genomic structure of the large
RNA segment of infectious bursal disease virus. Nucleic Acids Res. 14, 5001–5012.
Ismail, N.M., Saif, Y.M., Moorhead, P.D., 1988. Lack of pathogenicity of ﬁve serotype 2
infectious bursal disease viruses in chickens. Avian Dis. 32, 757–759.
Jagadish, M.N., Staton, V.J., Hudson, P.J., Azad, A.A., 1988. Birnavirus precursor
polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide.
J. Virol. 62, 1084–1087.
220 L. Wei et al. / Virology 417 (2011) 211–220Ji, W.T., Liu, H.J., 2008. PI3K-Akt signaling and viral infection. Recent Pat. Biotech. 2,
218–226.
Kallewaard, N.L., Bowen, A.L., Crowe, J.E., 2005. Cooperativity of actin and microtubule
elements during replication of respiratory syncytial virus. Virology 331, 73–81.
Lam, K., 1997. Morphological evidence of apoptosis in chickens infected with infectious
bursal disease virus. J. Comp. Pathol. 116, 367–377.
Lee, C.J., Liao, C.L., Lin, Y.L., 2005. Flavivirus activates phosphatidylinositol 3-kinase
signaling to block caspase-dependent apoptotic cell death at the early stage of virus
infection. J. Virol. 79, 8388–8399.
Liu, M., Vakharia, V.N., 2006. Nonstructural protein of infectious bursal disease virus
inhibits apoptosis at the early stage of virus infection. J. Virol. 80, 3369–3377.
Liu, J., Zhou, J., Kwang, J., 2002. Antigenic and molecular characterization of recent
infectious bursal disease virus isolates in China. Virus Genes 24, 135–147.
Lombardo, E., Maraver, A., Espinosa, I., Fernandez-Arias, A., Rodriguez, J.F., 2000. VP5,
the nonstructural polypeptide of infectious bursal disease virus, accumulates
within the host plasma membrane and induces cell lysis. Virology 277, 345–357.
Lukert, P.D., Saif, Y.M., 1997. Infectious bursal disease. Diseases of Poultry, 10th. Iowa
State University Press, Ames, IA, pp. 721–738.
Marte, B.W., Downward, J., 1997. PKB/Akt: connecting phosphoinositide 3-kinase to cell
survival and beyond. Trends Biochem. Sci. 22, 355–358.
McFerran, J.B., McNulty, M.S., McKillop, E.R., Connor, T.J., McCracken, R.M., Collins, D.S.,
Allan, G.M., 1980. Isolation and serological studies with infectious bursal disease
viruses from fowl, turkeys and ducks: demonstration of a second serotype. Avian
Pathol. 9, 395–404.
Mundt, E., Beyer, J., Müller, H., 1995. Identiﬁcation of a novel viral protein in infectious
bursal disease virus-infected cells. J. Gen. Virol. 76, 437–443.
Mundt, E., Kollner, B., Kretzschmar, D., 1997. VP5 of infectious bursal disease virus is not
essential for viral replication in cell culture. J. Virol. 71, 5647–5651.
Nair, P., Somasundaram, K., Krishna, S., 2003. Activated Notch1 inhibits p53-induced
apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7
oncogenes through a PI3K-PKB/Akt-dependent pathway. J. Virol. 77, 7106–7112.
Ojeda, F., Skardova, I., Guarda, M.I., Ulloa, J., Folch, H., 1997. Proliferation and apoptosis
in infection with infectious bursal disease virus: a ﬂow cytometric study. Avian Dis.
41, 312–316.
Pap, M., Cooper, G.M., 1998. Role of glycogen synthase kinase-3 in the phosphatidy-
linositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 273, 19929–19932.
Pawson, T., 1995. Protein modules and signalling networks. Nature 373, 573–580.
Shi, Y.K., Li, Y., Liu, Q., Anderson, D.H., Babiuk, L.A., Zhou, Y., 2007. SH3 bindingmotif 1 in
inﬂuenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation.
J. Virol. 81, 12730–12739.Shih,W.L., Kuo,M.L., Chuang, S.E., Cheng, A.L., Doong, S.L., 2000. Hepatitis B virus X protein
inhibits transforming growth factor-beta-induced apoptosis through the activation of
phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 275, 25858–25864.
Shin, Y.K., Liu, Q., Tikoo, S.K., Babiuk, L.A., Zhou, Y., 2007. Effect of the phosphatidylinositol
3-kinase/Akt pathway on inﬂuenza A virus propagation. J. Gen. Virol. 88, 942–950.
Snyder, D.B., Vakharia, V.N., Savage, P.K., 1992. Naturally occurring-neutralizing
monoclonal antibody escape variants deﬁne the epidemiology of infectious bursal
disease viruses in the United States. Arch. Virol. 127, 89–101.
Soares, J.A.P., Leite, F.G.G., Andrade, L.G., Torres, A.A., De Sousa, L.P., Barcelos, L.S., Teixeira,
M.M., Ferreira, P.C.P., Kroon, E.G., Souto-Padrón, T., Bonjardim, C.A., 2009. Activation
of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required
for both host survival and viral replication. J. Virol. 83, 6883–6899.
Spies, U., Müller, H., Becht, H., 1987. Properties of RNA polymerase activity associated
with infectious bursal disease virus and characterization of its reaction products.
Virus Res. 8, 127–140.
Spies, U., Müller, H., 1990. Demonstration of enzyme activities required for cap
structure formation in infectious bursal disease virus, a member of the birnavirus
group. J. Gen. Virol. 71, 977–981.
Sun,M., Fuentes, S.M., Timani, K., Sun, D.,Murphy, C., Lin, Y., August, A., Teng,M.N., He, B.,
2008. Akt plays a critical role in replication of nonsegmented negative-stranded
RNA viruses. J. Virol. 82, 105–114.
Tanimura, N., Sharma, J.M., 1998. In-situ apoptosis in chickens infected with infectious
bursal disease virus. J. Comp. Pathol. 118, 15–27.
Thomas, K.W., Monick, M.M., Staber, J.M., Yarovinsky, T., Carter, A.B., Hunninghake, G.W.,
2002. Respiratory syncytial virus inhibits apoptosis and induces NF-κB activity through a
phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 277, 492–501.
Van Den Berg, T.P., 2000. Acute infectious bursal disease in poultry: a review. Avian
Pathol. 29, 175–194.
Vasconcelos, A.C., Lam, K.M., 1994. Apoptosis induced by infectious bursal disease virus.
J. Gen. Virol. 75, 1803–1806.
Wu, Y.P., Hong, L.L., Ye, J.X., Huang, Z.Y., Zhou, J.Y., 2009. The VP5 protein of infectious
bursal disease virus promotes virion release from infected cells and is not involved
in cell death. Arch. Virol. 154, 1873–1882.
Yao, R., Cooper, G.M., 1995. Requirement for phosphatidylinositol-3 kinase in the
prevention of apoptosis by nerve growth factor. Science 267, 2003–2006.
Yao, K., Goodwin, M.A., Vakharia, V.N., 1998. Generation of a mutant infectious bursal
disease virus that does not cause bursal lesions. J. Virol. 72, 2647–2654.
Yao, K., Vakharia, V.N., 2001. Induction of apoptosis in vitro by the 17-kDa nonstructural
protein of infectious bursal disease virus: possible role in viral pathogenesis.
Virology 285, 50–58.
